Biopharmaceuticals
HIV/AIDS
Generics
Product Launch
News Release - February 1, 2018
Mylan Expands Access to HIV/AIDS Medicines with Launch of First Generic Sustiva(R) Tablets
Source: Mylan
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.